Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Human herpesvirus 6 and effectiveness of interferon β1b in multiple sclerosis patients.
National Cancer Institute Search for Clinical Trials
Treatment satisfaction, adherence and behavioral assessment in patients de - escalating from natalizumab to interferon beta.
Gender identity disorders and multiple sclerosis risk: A national record-linkage study.
Radiologic MS disease activity during natalizumab treatment interruption: findings from RESTORE.
The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.
Minocycline inhibits antigen processing for presentation to human T cells: additive inhibition with chloroquine at therapeutic concentrations.
Receptos reports third quarter 2013 financial results
Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis?
The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis.
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies: A Comparative Study.
Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system.
HLA-DRα1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis.
The Clinical Meaning of Walking Speed as Measured by the Timed 25-Foot Walk in Patients With Multiple Sclerosis.
Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patients.
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed.
Power estimation for non-standardized multisite studies.
Receptos to deliver scientific presentations about RPC1063 at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Receptos initiates clinical trials for S1P1 agonist program, aimed at multiple sclerosis
Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribine.
Optimizing IFN Beta - 1B Dose (Optims)
Cost-effectiveness analysis of interferon beta-1b as treatment for patients with clinically isolated syndrome suggestive of multiple sclerosis in Spain.
BRIEF-Health Canada approves Genzyme's Aubagio to treat relapsing remitting multiple sclerosis
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.

Pages